Efficacy News and Research

RSS

Review: Immunomodulatory therapies and nutritional significance of Ganoderma lucidum

According to the research published in Food & Functions recently, a team led by Prof. Huang Qing at the Institute of Intelligent Machines, Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences (CAS), reported for the first time an update and a comprehensive summary of the studies on the immunomodulatory therapies and nutritional significance of Ganoderma lucidum (G. lucidum) from 2010 to 2022, and confirmed that G. lucidum is an essential prebiotic for increasing bacterial flora and a health encouraging agent because of its components, primarily its abundant source of polysaccharides, triterpenoids, and polyphenols.

22 Feb 2023

CDC evaluation of the efficacy of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection in 3 to 5-year-olds

The complete primary series monovalent mRNA vaccines protect children aged three to five against symptomatic infection for up to four months.

22 Feb 2023

CDC provides vaccine efficacy estimates of Pfizer and Moderna vaccines in kids ages 3-5

Vaccination coverage among infants and children varied according to age, race and ethnicity, jurisdiction, and rural and urban settings

22 Feb 2023

RBD-NTD-subunit protein vaccine provides a promising booster vaccination strategy capable of protecting against known SARS-CoV-2 variants

Researchers assessed the impact of SARS-CoV-2 spike NTD incorporation into the RBD protein vaccine.

22 Feb 2023

Researchers explore Mediterranean diet and its health benefits in managing obesity

A review article published in the journal Experimental Gerontology describes the utility of Mediterranean diet (MedDiet) in the prevention and management of obesity.

22 Feb 2023

New analysis shows how convalescent plasma can be used as effective, low-cost COVID-19 treatment

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe.

22 Feb 2023

A growing burden of alcoholic hepatitis

A recent study published in the journal Medical Clinics of North America discussed the diagnosis, treatment, and pathophysiology of alcoholic hepatitis (AH).

21 Feb 2023

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

A retrovirus known as human T-cell lymphotropic virus type 1 (HTLV-1) is known to cause a number of diseases, including inflammatory diseases of the eye. Recently, researchers in Japan have investigated an antibody treatment for inflammatory eye disease in ocular cells infected with HTLV-1.

21 Feb 2023

Long-acting antiretroviral treatment may improve outcomes in underserved HIV patients

A long-acting antiretroviral treatment (LA-ART) given every four to eight weeks, and delivered with comprehensive support services, suppressed HIV in people who were previously not virologically suppressed.

21 Feb 2023

Testing new socialization and sex education curriculum for young people with developmental disabilities

The National Institutes of Health will award $3,906,026 over five years to researchers from the Institute for Implementation Science in Population Health at the CUNY Graduate School of Public Health and Health Policy to test the efficacy of a new socialization and sex education curriculum for young people with intellectual and developmental disabilities.

21 Feb 2023

Life Sciences Innovator Category Winner 2023

Following a rigorous application process, we are proud to announce that Seda have been selected as the UK Life Sciences Innovator Winner 2023 in the Application, Product & Service Design Category.

From Seda Pharmaceutical Development Services 21 Feb 2023

Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins

Researchers reported the circulation of a novel MERS-like coronavirus among Malayan pangolins, Manis javanica HKU4-associated CoV (MjHKU4r-CoV).

21 Feb 2023

MHRA authorizes new version of the Moderna ‘bivalent’ Covid vaccine

Authorization has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a new version of the Moderna 'bivalent' Covid vaccine (Spikevax) that targets both the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

21 Feb 2023

Propylene glycol prevents airborne transmission of respiratory viruses

Researchers assess the ability of propylene glycol to inactivate infection caused by respiratory viruses and prevent airborne transmission.

20 Feb 2023

Can social media influencers impact pregnancy and parenting?

A systematic review published in the journal Midwifery describes that social media influencers and bloggers can negatively and positively influence pregnant women and new parents and that the exposure may impact early parenting experiences and decision-making.

20 Feb 2023

Brexanolone inhibits key systemic inflammatory pathways associated with post-partum depression

Post-partum depression (PPD) develops after childbirth and affects both the mother's and the infant's health by preventing healthy bonding.

20 Feb 2023

Doxycycline taken after sex does not prevent bacterial STIs among cisgender women

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.

20 Feb 2023

Ketamine appears to hold promise in treating cocaine-use disorders

As cocaine use continues to climb across the United States, scientists have struggled to develop an effective pharmacological approach to treat the devastating disorder.

20 Feb 2023

Utilizing CRISPR to discover new therapy options for COPD

In this interview, we speak to Ceri Wiggins, a Director at AstraZeneca, about the many applications of CRISPR and its role in discovering new COPD therapies.

From Society for Laboratory Automation and Screening (SLAS) 20 Feb 2023

Prior COVID highly protective against severe disease ten months post-infection

In a recent study published in the Lancet, researchers performed a systematic review of scientific literature published from inception up to September 31, 2022, that documented the reduction in risk of coronavirus disease 2019 (COVID-19) among individuals with a prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vis-à-vis those with no COVID-19 history.

19 Feb 2023

Efficacy News and Research

Review: Immunomodulatory therapies and nutritional significance of Ganoderma lucidum

CDC evaluation of the efficacy of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection in 3 to 5-year-olds

CDC provides vaccine efficacy estimates of Pfizer and Moderna vaccines in kids ages 3-5

RBD-NTD-subunit protein vaccine provides a promising booster vaccination strategy capable of protecting against known SARS-CoV-2 variants

Researchers explore Mediterranean diet and its health benefits in managing obesity

New analysis shows how convalescent plasma can be used as effective, low-cost COVID-19 treatment

A growing burden of alcoholic hepatitis

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Long-acting antiretroviral treatment may improve outcomes in underserved HIV patients

Testing new socialization and sex education curriculum for young people with developmental disabilities

Life Sciences Innovator Category Winner 2023

Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins

MHRA authorizes new version of the Moderna ‘bivalent’ Covid vaccine

Propylene glycol prevents airborne transmission of respiratory viruses

Can social media influencers impact pregnancy and parenting?

Brexanolone inhibits key systemic inflammatory pathways associated with post-partum depression

Doxycycline taken after sex does not prevent bacterial STIs among cisgender women

Ketamine appears to hold promise in treating cocaine-use disorders

Utilizing CRISPR to discover new therapy options for COPD

Prior COVID highly protective against severe disease ten months post-infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News